[Clinicopathological conference: comments on the study of the first 400 patients].
D000005:Abdomen; D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D007327:Insufflation; D011027:Pneumoperitoneum; D011028:Pneumoperitoneum, Artificial / Q000627:therapeutic use*; D011030:Pneumothorax; D011031:Pneumothorax, Artificial / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D010131:Aminosalicylic Acid; D013307:Streptomycin
PARA-AMINOSALICYLIC ACID/therapeutic use; PNEUMOPERITONEUM, ARTIFICIAL/therapeutic use; PNEUMOTHORAX, ARTIFICIAL/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/therapy
COMENTARIO que surge del estudio de las primeras 400 enfermas internadas.